前沿论文｜CELL INTELLIGENCE

Engineering Strategies for Allogeneic T Cell-Based Platforms in Cancer Immunotherapy.

PubMed 2026/06/25 发表Pharmaceuticals (Basel)Q1 · IF 5.7（JCR 2025）

73.1分

★★★★☆

站内排序·非疗效

Invariant NKT cell-augmented GM-CSF-secreting tumor vaccine is effective in advanced prostate cancer model.

PubMed 2022/05/06 发表Cancer Immunol ImmunotherQ1 · IF 5.8（JCR 2025）

46.9分

★★★☆☆

站内排序·非疗效

Unveiling the Role of Tumor-Infiltrating T Cells and Immunotherapy in Hepatocellular Carcinoma: A Comprehensive Review.

PubMed 2023/10/19 发表Cancers (Basel)Q2 · IF 4.8（JCR 2025）

32.0分

★☆☆☆☆

站内排序·非疗效

前沿论文 3